Coastal Bridge Advisors, LLC Amgen Inc Transaction History

Coastal Bridge Advisors, LLC

$355 Million
Q2 2024

A detailed history of Coastal Bridge Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 4,896 shares of AMGN stock, worth $1.55 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

4,896

Previous 4,594 6.57%

Holding current value

$1.55 Million

Previous $1.31 Million 17.08%

% of portfolio

0.43%

Previous 0.33%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $79,350 - $96,431	302 Added 6.57%	4,896 $1.53 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.04%	4,594 $1.31 Million
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $1,022 - $1,153	-4 Reduced 0.09%	4,592 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $219,961 - $273,088	1,006 Added 28.02%	4,596 $1.24 Million
Q2 2023 Aug 16, 2023	BUY	$214.27 - $253.37 $428 - $506	2 Added 0.06%	3,590 $797,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $451 - $550	2 Added 0.06%	3,588 $867,000
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $23,361 - $29,683	102 Added 2.93%	3,586 $941,000
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $56,563 - $63,793	252 Added 7.8%	3,484 $785,000
Q2 2022 Nov 15, 2022	SELL	$230.71 - $256.74 $7,382 - $8,215	-32 Reduced 0.98%	3,232 $786,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $7,382 - $8,215	32 Added 0.99%	3,264 $794,000
Q4 2021 May 20, 2022	SELL	$198.88 - $227.6 $33,809 - $38,692	-170 Reduced 5.0%	3,232 $727,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $33,809 - $38,692	170 Added 5.26%	3,402 $765,000
Q3 2021 May 20, 2022	SELL	$212.27 - $248.7 $36,085 - $42,279	-170 Reduced 5.0%	3,232 $687,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $17,193 - $20,144	81 Added 2.44%	3,402 $723,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $11,679 - $12,957	50 Added 1.53%	3,321 $809,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $321,769 - $374,970	1,450 Added 79.63%	3,271 $814,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1,093 - $1,450	-6 Reduced 0.33%	1,821 $369,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $3,027 - $3,891	16 Added 0.88%	1,827 $440,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $226,878 - $265,953	1,361 Added 302.44%	1,811 $334,000
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $226,878 - $265,953	-1,361 Reduced 75.15%	450 $334,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $46,483 - $52,397	-257 Reduced 12.43%	1,811 $344,000
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $92,645 - $104,445	500 Added 31.89%	2,068 $429,000
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $44,999 - $50,544	271 Added 20.89%	1,568 $289,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $216,975 - $247,727	1,297	1,297 $242,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.

Account

Coastal Bridge Advisors, LLC Amgen Inc Transaction History